Westcotts advises Calleva on merger with Swedish nutraceutical brand
Will Mudd, Corporate Finance director at Westcotts, helped lead the M&A advisory team for Calleva
Westcotts Corporate Finance team has advised Calleva Limited on its merger with Wellma, a Swedish-based nutraceuticals and pharmaceuticals group, in what was a multi-million pound transaction.Calleva is a UK-based specialist in the development and manufacturing of nutraceutical ingredients and products in the forms of nutritional liquids and powder. It is recognised for its “high quality, innovative” formulations, and the products have a wide range of applications in sports nutrition, health, and lifestyle.